Five cases of permanent alopecia following chemotherapy

Korean Journal of Dermatology

Volumn 43, Issue 10, 2005, Pages 1365-1370

  Park, Jee Young ^a   Choi, Yoon Seok ^a   Lee, Weon Ju ^a   Lee, Seok Jong ^a   Na, Gun Yoen ^a   Kim, Do Won ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Busulphan; Chemotherapy; Permanent alopecia

Indexed keywords

ANTINEOPLASTIC AGENT; BUSPIRONE; BUSULFAN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MINOXIDIL; OLANZAPINE; TACROLIMUS; THIOTEPA; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALOPECIA; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CONVALESCENCE; DRUG MEGADOSE; DRUG WITHDRAWAL; EWING SARCOMA; GRAFT VERSUS HOST REACTION; HAIR GROWTH; HAIR LOSS; HAIR TRANSPLANTATION; HUMAN; INCIDENCE; KOREA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; RHABDOID TUMOR; RISK FACTOR;

EID: 29544449374     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Oh YS, Hong SH, Kye YC, Kim JS, Oh CH. A study of mucocutaneous manifestations due to cancer chemotherapy. Korean J Dermatol 1995;33:474-481
2. Chung JH, Cho KH, Kim NK. Cutaneous complications of cancer chemotherapy. Korean J Dermatol 1987;25:222-233
3. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2003:1337-1346
4. Baker BW, Wilson CL, Davis AL, Spearing RL, Hart DNJ, Heaton DC, et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant 1991;7:43-47
5. Hungssein AM. Chemotherapy-induced alopecia: New developments. South Med J 1993;86:489-496
6. Tran D, Sinclair RD, Schwarer AP, Chow CW. Permanent alopecia following chemotherapy and bone marrow transplantation. Australas J Dermatol 2000;41(2):106-108
7. de Jonge ME, Mathot RAA, Dalesio O, Huitema ADR, Rodenhuis S, Beijnen JH. Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy. Bone Marrow Transplant 2002;30:593-597
8. Cotsarelis G, Sun TT, Lavker RM. Label retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle and skin carcinogenesis. Cell 1990;61:1329-1337
9. Oliver RF. Whisker growth after removal of the dermal papilla and lengths of follicle in the hooded rat. J Embryol Exp Morphol 1966;15:331-347 (cited from ref. 6)
10. Joss RA, Riser J, Weston S, Brunner KW. Fighting alopecia in cancer chemotherapy. Recent Results Cancer Res 1998;108:117-125
11. Hymes SR, Simonton SC, Farmer ER, Beschorner WB, Tutschka PJ, Santos GW. Cutaneous busulphan effect in patients receiving bone-marrow transplantation. J Cutan Pathol 1985;12:125-129
12. Ljungman P, Hssen M, Bekassy AN, Ringden O, Oberg G. Busulphan concentration in relation to permanent alopecia in recipients of bone marrow tranplants. Bone Marrow Transplant 1995;15:869-871
13. Vowels M, Chan LL, Girl N, Russel S, Lam-Po-Tang R. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant 1993;12:347-350
14. Sulivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267-276